NCT05961865View on ClinicalTrials.gov

Change in Inflammatory State in Patients Undergoing Transcatheter Ablation of Atrial Fibrillation

RecruitingOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

July 11, 2023

Primary Completion Date

July 31, 2027

Study Completion Date

August 31, 2027

Conditions
Atrial FibrillationMarker of InflammationInflammationArrhythmia
Interventions
DIAGNOSTIC_TEST

Markers of inflammation and fibrosis

"Will be analyzed the following inflammation markers:~Interleukin 6, N-terminal propeptide of type 1 procollagen (P1NP), chitinase-3-like protein 1 (YKL-40), tumor necrosis factor (TNF-alpha), GlycA, proprotein convertase subtilisin/kexin type 9 and omega-3 fatty acids."

Trial Locations (1)

20122

RECRUITING

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan

All Listed Sponsors
collaborator

University of Milan

OTHER

lead

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER